PlasmaTech Biopharmaceuticals Appoints World Leading Plasma Experts to Scientific Advisory Board
PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing patient care in critical areas, announced the appointment of leading experts to its newly formed scientific advisory board ("SAB"). The appointed SAB will serve as a strategic resource to the company as it continues to develop and commercialize its proprietary plasma fractionation platform, Salt Diafiltration Process ("SDF™").
View full press release